Dernières nouvelles

Information non disponible

26 enregistrements « 1 de 3 »

Bélanger C, Aubin S, Lavallée MC, Beaulieu L

Simultaneous catheter and multicriteria optimization for HDR cervical cancer brachytherapy with a complex intracavity/interstitial applicator

Article de revue

Med Phys, 51 (3), 2024.

Résumé | Liens:

Tho D, Bélanger C, Jørgensen EB, Tanguay J, Rosales HML, Beddar S, Johansen JG, Kertzscher G, Lavallée MC, Beaulieu L

Establishing a fingerprinting method for fast catheter identification in HDR brachytherapy in vivo dosimetry

Article de revue

Brachytherapy, 23 (2), 2024.

Résumé | Liens:

Lavallee MC, Cantin A, Aubin S, Lefebvre M, Marrier AS, Bouchard I, Fiset C, Villeneuve-Gauthier A, Foster W, Martin AG, Carignan D, Beaulieu L, Vigneault E

US-guided EM tracked system for HDR brachytherapy: A first in-men randomized study for whole prostate treatment

Article de revue

Brachytherapy, 23 (1), 2024.

Résumé | Liens:

Beaudry MM, Carignan D, Foster W, Lavallee MC, Aubin S, Lacroix F, Poulin E, Lachance B, Després P, Beaulieu L, Vigneault E, Martin AG

Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial

Article de revue

Clin Transl Radiat Oncol, 40 , 2023.

Résumé | Liens:

Tho D, Lavallée MC, Beaulieu L

A scintillation dosimeter with real-time positional tracking information for in vivo dosimetry error detection in HDR brachytherapy

Article de revue

J Appl Clin Med Phys, 24 (12), 2023.

Résumé | Liens:

Ouellet S, Lemaréchal Y, Berumen-Murillo F, Lavallée MC, Vigneault É, Martin AG, Foster W, Thomson RM, Després P, Beaulieu L

A Monte Carlo dose recalculation pipeline for durable datasets: an I-125 LDR prostate brachytherapy use case

Article de revue

Phys Med Biol, 68 (23), 2023.

Résumé | Liens:

Lavallée MC, Cantin A, Monéger F, Lefebvre M, Foster W, Vigneault E, Beaulieu L

Commissioning of an intra-operative US guided prostate HDR system integrating an EM tracking technology

Article de revue

Brachytherapy, 20 (6), 2021.

Résumé | Liens:

Tho D, Lavallee MC, Beaulieu L

Performance of an enhanced afterloader with electromagnetic tracking capabilities for channel reconstruction and error detection

Article de revue

Med Phys, 48 (8), 2021.

Résumé | Liens:

Ben Aicha I, Hathout L, Carignan D, Després P, Lavallée MC, Aubin S, Beaulieu L, Lacroix F, Foster W, Martin AG, Vigneault E

Dose to the bladder neck is not correlated with urinary toxicity in patients with prostate cancer treated with HDR brachytherapy boost

Article de revue

Brachytherapy, 19 (5), 2020.

Résumé | Liens:

Guimond E, Lavallée MC, Foster W, Vigneault É, Guay K, Martin AG

Impact of a dominant intraprostatic lesion (DIL) boost defined by sextant biopsy in permanent I-125 prostate implants on biochemical disease free survival (bDFS) and toxicity outcomes

Article de revue

Radiother Oncol, 133 , 2019.

Résumé | Liens:

26 enregistrements « 1 de 3 »
Signaler des ajouts ou des modifications